Solid Biosciences Inc. (SLDB) stock
SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.23−0.25 (-3.86%)
Close on Nov 17, 2026Market cap $668.01MP/E –Yield –
Solid Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Solid Biosciences's price to sales ratio was 23.7× on Feb 29, 2024, against 8.1× a year earlier. Over the last 2 years it ranged from 3.0× to 23.7×, with a median of 7.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Feb 29, 2024 | 23.7× | +8.4 |
| 2023 | Dec 29, 2023 | 15.2× | +12.2 |
| 2022 | Dec 30, 2022 | 3.0× | – |
See a number that looks wrong?